Agios Pharmaceuticals AGIO Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$422.6M— | -$412.78M— | —— | —— | —— | ||
| $5.26M-5.7% | $5.18M-8.4% | $5.28M-7.2% | $5.25M-12.0% | $5.58M-9.7% | ||
| $56.73M+26.2% | $52.55M+22.7% | $49.33M+7.8% | $48.1M+10.1% | $44.97M+2.5% | ||
| -$380.41M+5.2% | -$372.98M+4.3% | -$409.93M-24.5% | -$406M-32.4% | -$401.46M-33.5% | ||
| $4.32M+87.0% | $4.32M+156% | $4.16M+337% | $3.03M+236% | $2.31M+210% | ||
| $405.91M— | $377.18M— | —— | —— | —— | ||
| $9.14M-10.4% | $8.68M-39.9% | $10.96M+4.9% | $9.16M-5.5% | $10.2M+15.5% | ||
| —— | —— | -$161.02M— | -$3.65M— | -$39.8M— | ||
| -$384.73M+4.7% | -$377.29M+3.6% | -$414.09M-25.4% | -$409.03M-33.0% | -$403.77M-33.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Agios Pharmaceuticals generate?
- Agios Pharmaceuticals (AGIO) generated -$380.4M in operating cash flow over the trailing twelve months.
- What is Agios Pharmaceuticals's free cash flow?
- After $4.3M of capital expenditures, Agios Pharmaceuticals's free cash flow was -$384.7M over the trailing twelve months, up 4.7% year over year.
- Where does Agios Pharmaceuticals's cash flow data come from?
- Every line is extracted from Agios Pharmaceuticals's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
